1167.HK
Price:
$8.84
Market Cap:
$6.30B
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-634...[Read more]
Industry
Biotechnology
IPO Date
2020-12-21
Stock Exchange
HKSE
Ticker
1167.HK
According to Jacobio Pharmaceuticals Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -126.29. This represents a change of 86.54% compared to the average of -0.15 of the last 4 quarters.
The mean historical PE Ratio of Jacobio Pharmaceuticals Group Co., Ltd. over the last ten years is -19.54. The current -126.29 PE Ratio has changed 64.54% with respect to the historical average. Over the past ten years (40 quarters), 1167.HK's PE Ratio was at its highest in in the December 2024 quarter at 17.27. The PE Ratio was at its lowest in in the December 2018 quarter at -32.21.
Average
-19.54
Median
-9.34
Minimum
-64.43
Maximum
-5.91
Discovering the peaks and valleys of Jacobio Pharmaceuticals Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 395.79%
Maximum Annual PE Ratio = -5.91
Minimum Annual Increase = -77.05%
Minimum Annual PE Ratio = -64.43
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -5.94 | -15.92% |
| 2023 | -7.06 | -24.40% |
| 2022 | -9.34 | -68.13% |
| 2021 | -29.30 | 395.79% |
| 2020 | -5.91 | -60.03% |
| 2019 | -14.79 | -77.05% |
The current PE Ratio of Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.44
5-year avg
-11.51
10-year avg
-19.54
Jacobio Pharmaceuticals Group Co., Ltd.’s PE Ratio is less than Qyuns Therapeutics Co., Ltd. (-20.17), less than Viva Biotech Holdings (24.96), less than TYK Medicines, Inc (-10.38), less than AIM Vaccine Co., Ltd. (-13.63), less than Jiangxi Rimag Group Co., Ltd. (-92.31), less than Ocumension Therapeutics (-23.28), less than Medtide Inc. (0), less than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-7.60), less than Tong Ren Tang Technologies Co. Ltd. (12.06), less than Yidu Tech Inc. (-40.64),
| Company | PE Ratio | Market cap |
|---|---|---|
| -20.17 | $4.27B | |
| 24.96 | $4.11B | |
| -10.38 | $4.93B | |
| -13.63 | $4.17B | |
| -92.31 | $3.39B | |
| -23.28 | $6.54B | |
| 0 | $4.04B | |
| -7.60 | $2.46B | |
| 12.06 | $5.75B | |
| -40.64 | $5.33B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jacobio Pharmaceuticals Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jacobio Pharmaceuticals Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Jacobio Pharmaceuticals Group Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the highest PE Ratio for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the 3-year average PE Ratio for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the 5-year average PE Ratio for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
How does the current PE Ratio for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) compare to its historical average?